Oculis Holding AG (OCS) Tax Rate (2022 - 2026)
Oculis Holding AG's (OCS) quarterly Tax Rate came in at 0.34% in Q1 2026, down 36.0% year-on-year from 0.53% in Q1 2025, and down 100.1% quarter-over-quarter from 345.27% in Q4 2025.
Oculis Holding AG (OCS) Tax Rate (2022 - 2026) Analysis & Trends
Oculis Holding AG's Tax Rate history runs 5 years deep, the most recent figure standing at 0.34% for Q1 2026.
- On a quarterly basis, Tax Rate fell 36.0% year-over-year to 0.34% in Q1 2026; TTM through Mar 2026 was 0.56%, a 47.0% increase from a year earlier, with the FY2025 full-year figure at 0.19%, changed 0.0% from the prior year.
- Tax Rate eased to 0.34% in Q1 2026 per OCS's latest filing, from 345.27% in the prior quarter.
- Across five years, Tax Rate topped out at 345.27% in Q4 2025 and bottomed at 0.82% in Q4 2024.
- The 5-year median for Tax Rate is 0.07% (2025), against an average of 21.57%.
- Across the five-year window, Tax Rate sank 75 bps in 2024 and soared 34609 bps in 2025, its largest moves.
- Year by year, Tax Rate stood at 0.15% in 2022, then surged by 32 bps to 0.1% in 2023, then tumbled by 693 bps to 0.82% in 2024, then soared by 42015 bps to 345.27% in 2025, then sank by 100 bps to 0.34% in 2026.
- Per Business Quant, the three latest OCS Tax Rate figures stand at 0.34% (Q1 2026), 345.27% (Q4 2025), and 0.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 7.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.34 |
| Mar 31, 2026 | -0.34 |
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | 345.27 |
| Dec 31, 2025 | 345.27 |
| Dec 31, 2025 | 345.27 |
| Sep 30, 2025 | 0.08 |
| Sep 30, 2025 | 0.08 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | -0.82 |
| Dec 31, 2024 | -0.82 |
| Dec 31, 2024 | -0.82 |
| Sep 30, 2024 | 0.09 |
| Sep 30, 2024 | 0.09 |